RNA editing in the parasitic organism Trypanosoma brucei is characterised by the insertion and deletion of uridylate residues into otherwise incomplete primary transcripts. The processing reaction is a required pathway for the expression of most mitochondrial genes and proceeds by a cascade of enzyme-catalysed steps. RNA editing involves one or more macromolecular ribonucleoprotein complexes which are likely to interact with additional components as the reaction proceeds. Here we examined the involvement of the gRNA-binding polypeptide gBP21, a protein which has been demonstrated to be associated with active RNA editing complexes. We show that in vitro RNA editing can be suppressed by the addition of a gBP21-specific antibody or by immunodepletion of the protein. By creating a gBP21 knockout mutant we analysed the requirement for the protein in vivo. gBP21 -trypanosomes are viable as bloodstream stage cells and contain edited mRNAs. However, the knockout mutant is not capable of differentiating from the bloodstream to the insect life cycle stage in vitro. Moreover, mutant cells are characterised by a low mitochondrial transcript abundance. Together, these data establish that gBP21 contributes a non-essential function to the RNA editing reaction and further suggest that the protein is involved in additional mitochondrial processes which impact a larger pool of mitochondrial transcripts.
INTRODUCTION
Mitochondrial gene expression in kinetoplastid organisms requires an unusual RNA processing reaction, termed RNA editing (for recent reviews see [1] [2] [3] . The process is characterised by the site-specific insertion or deletion of exclusively uridylate (U) residues into otherwise non-translatable precursor mRNAs (pre-mRNAs). Trans-acting RNA molecules, known as guide (g)RNAs, provide the information for the processing reaction via base pairing to the pre-edited mRNAs and thus have a template-like function. Evidence from RNA editing in vitro systems (4-7) led to the conclusion that mechanistically an RNA editing reaction cycle relies on the consecutive action of three enzymatic activities: (i) a gRNA-dependent endonuclease; (ii) a terminal uridylyltransferase/nuclease; (iii) an RNA ligase. These activities presumably act within one or more high molecular mass ribonucleoprotein (RNP) complexes (8) (9) (10) (11) which likely interact with additional factors as the reaction proceeds. Several candidate proteins have been identified: mHel61p (12) , a putative RNA helicase, that was suggested to act during the displacement of gRNAs from fully edited mRNA domains; TBRGG1 (13) , an oligo(U)-binding polypeptide; REAP-1, an RNA editing complexassociated protein (14) . Other potentially participating components are proteins that have been shown to specifically interact with gRNAs (15) (16) (17) . One such protein is gBP21, an arginine-rich polypeptide with a calculated molecular mass of ∼21 kDa. gBP21 was isolated from Trypanosoma brucei mitochondrial lysates by zero distance crosslinking to synthetic, radioactively labelled gRNAs (18) . The basic protein is nuclear encoded and translates as a pre-protein containing a putative mitochondrial import sequence. Binding to gRNAs occurs at a defined structural domain consisting of a stem-loop secondary structure element (19) . Although gBP21 does not contain any known RNA-binding motif, a high affinity dissociation constant (K d ) in the range of 10 nM has been determined for the protein-RNA association. The interaction was characterised to depend, in part, on ionic contacts and does not induce gross structural alterations within the gRNA molecule. However, gRNAs complexed with gBP21 have been shown to exhibit an increased stability compared with the non-complexed RNAs (18) . Next to the gRNA-binding capacity of gBP21, Allen et al. (20) demonstrated that the protein, under steady-state conditions, is physically associated with active RNA editing complexes. This might either be the result of a temporal, factor-like binding of gBP21 to the editing machinery or reflect a participation of the protein as an integral component of the editing RNP complex(es).
In this study, we describe experiments that test the possibility of an involvement of gBP21 during the RNA editing reaction cycle. We show that a subpopulation of the protein co-localizes with an in vitro RNA editing activity and that the activity can be inhibited below the level of detection by the addition of a gBP21-specific antibody or by immunodepletion. We further report the generation of a double allele gBP21 knockout trypanosome strain. These cells grow moderately slower than wild-type trypanosomes and are no longer capable of undergoing differentiation from the bloodstream to the insect life cycle stage in vitro. On a molecular level, the double knockout cell line is characterised by a reduced mitochondrial transcript abundance, although the cells are still capable of editing pre-mRNAs. Together, these results suggest a non-essential function of gBP21 during RNA editing.
MATERIALS AND METHODS

Trypanosome cell growth, preparation of extracts and subcellular fractionation
The insect (procyclic) life cycle stage of the T.brucei serodeme IsTaR 1 (21) was grown at 27_C in SDM-79 medium supplemented with 10% (v/v) heat-inactivated bovine foetal calf serum (FCS) (22) . Bloodstream trypanosomes (stock 427, variant MITat 1.4) (23) were grown in HMI-9 medium (24) at 37_C in 5% CO 2 /95% air. Parasite cell densities were determined by automated cell counting. Whole cell trypanosome lysates were prepared as in Maizel et al. (25) . The preparation of mitochondrial vesicles followed the protocol of Harris et al. (26) . Detergent lysates of the vesicle preparations were prepared as described (27) using 1% (v/v) Triton X-100 (75-fold CMC). Protein concentrations were determined according to Bradford (28) .
In vitro differentiation assay
The differentiation of bloodstream form trypanosomes to insect stage cells was performed in vitro by transferring exponentially growing bloodstream cells into SDM-79 medium containing 10% (v/v) heat-inactivated FCS (22) . The temperature was shifted from 37 to 27_C and the medium was supplemented with citric acid and cis-aconic acid to final concentrations of 3 mM each (29, 30) . Exponential growth resumed after a lag period of ∼48 h.
Oligodeoxynucleotides
DNA oligonucleotides of the following sequences were synthesized by automated solid-support chemistry using O-cyanoethyl-N,Ndiisopropyl-phosphoramidites: gbp21-ko1  CGCTGGAGCTCCTTCACTGCGTAAGAGA  gbp21-ko2  CGCTGGTACCAGTTGTGGGTACTGAGA  gbp21-ko3  CGCTATCGATGTTTCGTCAGCACTATGCCA  gbp21-ko4  CGCTGTCGACTGCTCACTTGCATTGCAC  COI-RT  GTAATGAGTACGTTGTAAAACTG  COII-RT  ATTTCATTACACCTACCAGG  Cyb-RT  CAACCTGACATTAAAAGAC  A6-RT  CTTATTTGATCTTATTCTATAACTCC  ND7-RT  CACATAACTTTTCTGTACCACGATGC  Hel64-RT  GGTTACTTTGTTGAACG  α-TUB-RT  GGGGGTCGCACTTTGTC  gND7-506-RT  AAAATTCACTATATA  gND7-506-RT-PCR CGATGTAAATAACCTG  gA6-14-RT  AAAATAATTATCATATC  gA6-14-RT-PCR  CTATAACTCCGATAACG  Neo-5′  CTGCCGAGAAAGTATCC  Neo-3′  AAGGCGATAGAAGGCGATG  Hyg-5′  ACCGCAAGGAATCGGTC  Hyg-3′  TCTGCGGGCGATTTGTG  gBP21-5′  GCCACATCATCGCATGG  gBP21-3′ CGAAACCCGAAGCTCTCG
Preparation of nucleic acids and Southern blotting
Trypanosoma brucei genomic DNA was prepared as described (31) . Digestion of DNA, agarose gel electrophoresis and transfer of nucleic acids onto nylon membranes followed standard protocols (31) . Hybridisations were performed with randomly primed digoxigenin-11-dUTP or [α-32 P]dATP-labelled probes; the templates were obtained by PCR from relevant plasmids (neo probe 470 nt; hyg probe 500 nt; gBP21 probes 195, 250 and 955 nt). Hybridised fragments were detected with an anti-digoxigenin alkaline phosphatase-conjugated antibody in conjunction with a digoxigenin luminescence detection reaction or by autoradiography. Whole cell RNA from bloodstream and procyclic stage trypanosomes was isolated according to Chomczynski and Sacchi (32) .
Primer extension analysis and reverse transcription (RT)-PCR
Primer extensions were performed with 15-40 µg whole cell RNA and 0.1-2 pmol 5′-32 P-labelled oligodeoxynucleotide primer. Samples were heated to 65_C for 60 min before cooling to 20_C at a rate of 0.02_C/s. Extension reactions were performed in 50 mM Tris-HCl, pH 8.3, 50 mM KCl, 10 mM MgCl 2 , 5.5 mM DTT, 150 µM each dATP, dCTP and dTTP and 75 µM ddGTP in addition to 10 U AMV reverse transcriptase. In cases where the reaction was terminated by the addition of ddCTP (75 µM) the nucleotide mix contained 150 µM each dATP, dGTP and dTTP. Incubation was for 45 min at 47_C. RNA was removed by RNase A digestion, reaction products were precipitated with ethanol and fractionated in urea (8 M)-containing 10% (w/v) polyacrylamide gels. Gels were analysed by autoradiography followed by densitometry. The abundance of gRNAs in whole cell RNA preparations was determined by RT-PCR (33) using an amplification scheme derived from a series of control experiments with synthetic gA6-14 and gND7-506 transcripts to ensure that the accumulation of PCR products was below saturation.
Gene disruption experiments
Constructs used for the disruption of the gBP21 gene are based on plasmid p25kPEP-12 which contains the entire gBP21 open reading frame (ORF) including 146 bp of 5′-untranslated region (UTR) and 255 bp of 3′-UTR. Plasmid p25kPEP-12 was digested at a unique intragenic SphI site and processed with T4 DNA polymerase to remove 4 nt. The blunt-ended DNA was circularised and the plasmid was named p25kpep-12(∆SphI). Translation of the mutated gBP21 gene should produce only the first four amino acids before a frameshift occurs. The cloning of gBP21 5′ sequences into pHD102 (neo gene-containing plasmid) (34) and pHD132 (hyg gene-containing plasmid) (35) was performed as follows. Primers gbp21ko1 and gbp21ko2 were used to amplify 5′ DNA (335 bp) from p25kpep-12(∆SphI). SacI and KpnI restriction sites present in these primers were used to clone the PCR product into SacI + KpnI-digested pHD102 and pHD132. The resulting plasmids were called pHD102-gbp21(5′) and pHD132-gbp21(5′). Inserts of both plasmids containing the 5′ gBP21 sequences and the antibiotic resistance genes were then moved to pBluescript II SK(-): pHD102-gbp21(5′) and pHD132-gbp21(5′) were cut with SacI and StuI. (318 bp) were amplified from 25kpep-12(∆SphI) using primers gbp21ko3 and gbp21ko4. The ClaI and SalI sites present in these primers were used to clone the PCR product into XhoI and ClaI restricted pBluescript II SK(-) to yield pBSCR II SK(-)-gbp21(3′). For the cloning of gbp21-3′ DNA from pBSCR II SK(-)-gbp21(3′) into pBS-neo-5′gbp21 and pBS-hyg-5′gbp21, all plasmids were digested with ApaI and ClaI. The insert of pBSCR II SK(-)-gbp21(3′) was ligated into the doubly digested pBS-neo-5′gbp21 and pBS-hyg-5′gbp21 to yield pNeo-gbp21 and pHyg-gbp21. These plasmids were restricted with ApaI and SacI to release the neo or hyg cassettes now flanked by gBP21 5′ and 3′ sequences for targeting experiments. Transfection of T.brucei insect stage cells was done essentially as described (36) . Antibiotic selection was started after overnight incubation using 25 µg/ml of G418 (neo transfectants) and hygromycin B (hyg transfectants). After 48 h, the concentration of both drugs was further increased to 50 µg/ml. Outgrowth of the transfected cells was seen after 10-12 days.
Bloodstream stage trypomastigotes were transfected as described (37, 38) . Selection pressure was applied after ∼18 h. Clonal cell lines were established by limited dilution.
Fractionation of mitochondrial lysates and RNA editing assay
Cleared mitochondrial lysates (2-13 mg) in 20 mM HEPES, pH 8.3, 30 mM KCl, 10 mM Mg(OAc) 2 , 5 mM CaCl 2 , 0.5 mM DTT, 1% (v/v) Triton X-100, 1 mM PMSF, 1 µg/ml leupeptin and 10 µg/ml bovine trypsin inhibitor were fractionated by density centrifugation in linear 10-35% (v/v) glycerol gradients (8) .
Centrifugation was performed in a Beckman SW 41 rotor at 38 000 r.p.m. for 5 h at 4_C. Twelve 1 ml fractions were collected from the top of the gradient. All fractions were tested for their in vitro RNA editing activity as described (39) . Apparent sedimentation coefficients were determined using the following markers: 5S rRNA from Escherichia coli, thyroglobulin (19.3S), E.coli 23S rRNA, E.coli 30S ribosomal subunit and E.coli 50S ribosomal subunit.
Preparation of recombinant (r-)gBP21, production and purification of anti-gBP21 antibodies and immunoblotting
Recombinant gBP21 was prepared as described (18) . Anti-gBP21 antibodies were raised in rabbits and affinity purified as described (40) . For immunoblotting, protein extracts were separated in SDS-containing polyacrylamide gels and transferred to nitrocellulose membranes. Membranes were blocked with 5% (w/v) bovine serum albumin (BSA) in phosphate-buffered saline (PBS) and probed with the antibodies. Detection was performed by enhanced chemiluminescence.
Antibody immobilisation and immunodepletion
Affinity purified anti-gBP21 antibodies (75-140 µg) were coupled to 350-500 µl wet bead material of protein A-Sepharose CL-4B (Pharmacia) by overnight incubation in PBS at 4_C with gentle stirring. Bound antibodies were cross-linked with 20 mM dimethylpimelimidate in 200 mM Na-borate, pH 9, as described (41) . Antibody coupled beads were washed in 20 mM HEPES pH 8.3, 30 mM KCl, 10 mM Mg(OAc) 2 and were either used directly or stored in the same buffer containing 0.1% (w/v) sodium azide at 4_C. Immunodepletion of editing-active mitochondrial fractions was performed by batch affinity chromatography using antibody coupled beads (30-50 µl) which were blocked for non-specific adsorption with acetylated BSA (1 mg/ml) for minimally 3 h at 4_C. After washing, an equal volume of editing-active glycerol gradient fraction (≥0.2 mg/ml protein) was added and incubated overnight at 4_C with gentle rotational stirring. The depleted supernatant was removed from the bead material, added to an equal volume of fresh antibody coupled beads and incubated for an additional 4-5 h at 4_C. Depletion efficiencies were measured by immunoblotting. Immunodepleted samples were analysed for their in vitro RNA editing activity as described (39) .
RESULTS
Inhibition of RNA editing in vitro
The finding that gBP21 is associated with active RNA editing complexes (20) tempted us to test whether an anti-gBP21 antibody would be capable of inhibiting RNA editing in vitro. For the experiment we made use of a polyclonal antiserum which was raised against r-gBP21 (18). The serum was affinity purified (40) and added to an in vitro RNA editing reaction (39) . The assay monitors the gRNA-dependent deletion of four uridylate residues from a synthetic radiolabelled pre-mRNA and requires mitochondrial protein.
Next to the formation of the editing product, the assay is capable of identifying 3′ pre-mRNA cleavage intermediates and chimeric gRNA/mRNA side products. Figure 1 shows a representative example. The addition of the lowest amount of anti-gBP21 antibody (0.3 µg) causes a 25% inhibition in the formation of the editing product. A 10-fold higher concentration results in the complete inhibition of editing product formation, in addition to abolishing pre-mRNA cleavage and gRNA/mRNA chimera formation. By contrast, the same amount of an antiHsp60 antibody or of BSA had no effect on the in vitro reaction. In a follow-up experiment, we measured the residual editing activity of mitochondrial extracts immunodepleted of gBP21. The activity was below the level of detection (data not shown) and could not be restored by the addition of recombinant gBP21 protein. This likely indicated a co-precipitation of other editing components similar to the published data by Allen et al. (20) who used a monoclonal anti-gBP21 antibody.
Creation of a gBP21 knockout trypanosome cell line
Although the previous results were indicative of a potential involvement of gBP21 in the RNA editing process, a distinction between a mere structural contribution or a functional participation could not be made. In order to test whether the protein is essential for RNA editing we decided to perform the targeted disruption of all gBP21 genes and to analyse the phenotype of the knockout mutant. As a first step, we determined the gene copy number of gBP21 by probing gel separated restriction enzyme fragments of T.brucei genomic DNA with gBP21-specific DNA probes (data not shown). The data identified gBP21 as a single copy gene and as such it represented an ideal target for a disruption analysis. Figure 2A shows a partial genomic map of the gBP21 locus derived from these experiments.
Initially, we performed the transfection/disruption experiments with insect stage trypanosomes which rely on mitochondrial function and thus RNA editing for cell survival (reviewed in 42). Although we were able to create a single allele knockout strain, all attempts to disrupt both gBP21 alleles in these cells failed. Since bloodstream trypanosomes do not require mitochondrial activity for their energy metabolism (42), we reasoned that they might tolerate the disruption of a potentially essential mitochondrial protein. Therefore, all subsequent experiments were performed with bloodstream trypomastigote cells grown under axenic culture conditions (24) .
In a first round of transfection we replaced one wild-type gBP21 allele with a gBP21::neo construct (Fig. 2B) . The neomycin-resistant cell line was then subjected to a second round of transfection using a gBP21::hyg DNA fragment (Fig. 2B) . Cells resistant to both antibiotics were cloned and tested for the gBP21 null/null genotype. A characteristic Southern blot is shown in Figure 3A . The double knockout cell line did not contain undisrupted gBP21 sequences any more and, as expected, proved to be positive for the two antibiotic resistance marker genes. An immunoblot analysis of whole cell protein lysates further confirmed the absence of gBP21 protein in the double knockout cell line (Fig. 3B, upper) . As a control, we reprobed the same blot with an antibody against Hsp60, another mitochondrial protein.
No difference between wild-type and the mutant lacking gBP21 was observed (Fig. 3B, lower) . Similarly, a light microscope examination of the mutant trypanosomes revealed no gross morphological differences from wild-type cells (data not shown). However, double knockout cells multiplied notably more slowly (6.0 ± 0.2 versus 5.1 ± 0.3 h for wild-type cells).
In summary, we concluded that one gBP21 allele is sufficient for survival in insect stage trypanosomes. The protein is not essential during the bloodstream life cycle stage, although the absence of the polypeptide resulted in a reduced growth rate phenotype.
Differentiation from bloodstream to insect stage trypanosomes in vitro
To address the question of whether gBP21 is an essential gene in insect stage trypanosomes, we decided to perform differentiation experiments under in vitro conditions. Bloodstream trypomastigotes can be triggered to undergo the differentiation to the procyclic life cycle stage by transferring the cells into insect stage-specific medium (22) which requires supplementation with sodium cis-aconitate (29, 30, 43, 44) . The process is further initiated by a down-shift in the incubation temperature from 37 to 27_C. We compared wild-type trypanosomes and the gBP21 null/null mutant in the analysis and monitored cell growth over time after the start of the differentiation event (Fig. 4) . During an initial period of 48 h the majority of cells (≥75%) in both cell lines died. After that interval the remaining wild-type cells started to grow and could be established as procyclic stage cells. In contrast, at no Hybridisation was performed with a gBP21-specific probe (left, gBP21), a neomycin phosphotransferase-specific probe (centre, Neo) and a hygromycin phosphotransferase-specific probe (right, Hyg). The gBP21 gene is characterised by a 1.8 kb BamHI fragment. Integration of the neo cassette generated a 3.4 kbp BamHI fragment and the integration of the hyg disruption construct was identified by a 3.5 kb BamHI fragment (see Fig. 2 time point after the induction of differentiation did the gBP21 null/null mutant cells resume growth and ultimately all cells died (Fig. 4) . The gBP21 single allele knockout strain was able to differentiate and was established as a procyclic stage cell line. These cells grew with a doubling time of 8.3 ± 0.3 h, identical to wild-type cells (8.1 ± 0.1 h). Thus, we concluded that gBP21 is a protein component which is either required for the differentiation event or essential during the procyclic life cycle stage.
RNA editing in gBP21 null/null trypanosome cells
The gBP21 null/null mutant was viable as a bloodstream stage trypanosome. Although mitochondrial function is down-regulated during this life cycle stage, several mitochondrial pre-mRNAs have been shown to be edited (for a review see 45) . Assuming that the editing machinery in both life cycle stages is identical, we tested whether the reaction per se can be performed in the absence of gBP21 protein. As an assay system we performed a comparative 'poisoned' primer extension analysis (46) of specific mRNAs from whole cell steady-state RNA isolates of wild-type trypanosomes and gBP21 null/null mutant cells.
The abundance of mitochondrial mRNAs in bloodstream stage trypanosomes has been shown to vary in a transcript-specific manner and we decided to look at the mRNA for cytochrome oxidase II (COII) first. Although this transcript is down-regulated in this life cycle stage, edited COII mRNA can be identified (47) . Cytochrome oxidase I (COI), as a never-edited mRNA, and apocytochrome b (Cyb), which is not expressed in bloodstream trypanosomes, were selected as control transcripts (45, 47) . Primer molecules were designed to simultaneously detect the edited and unedited mRNA versions.
A representative result of the primer extension analysis is shown in Figure 5 . As expected, in both cell lines no edited Cyb mRNA was detected (Fig. 5A) . In contrast, an RNA preparation from wild-type procyclic stage trypanosomes showed a strong signal for the edited Cyb mRNA. Never-edited COI transcripts were detected in both cell lines and, as shown before (45, 47) , were less abundant in comparison with the amount of wild-type insect stage cells. This essentially confirmed the bloodstream features of the two RNA isolates. However, a comparison of the COI transcript level in the wild-type and gBP21 null/null mutant showed a further reduction in the double knockout cells. If the signal intensity in wild-type cells was set to 100%, then the intensity in the gBP21 double knockout sample amounted to only 32%. The same phenomenon was seen for the unedited COII transcript, which decreased to only 7%. Although edited COII mRNA was detectable in wild-type cells, no signal could be visualised in the gBP21 knockout cell line. This could be interpreted as an absence of edited transcripts in the mutant cell line; because of the already reduced transcript level of unedited COII mRNA, however, we were concerned that this simply reflected a detection problem.
As a consequence, we tested for mRNAs which are constitutively expressed or even up-regulated during the bloodstream life cycle stage. Figure 5B shows such an analysis for the mRNAs coding for A6 and ND7. A6 is transcribed at approximately equal levels in both life cycle stages, whereas the mRNA for ND7 is ∼10-fold (45, 48, 49) . In contrast to the situation with COII, the edited versions of both mRNAs were clearly detectable in both cell lines. Thus, RNA editing can be performed in the absence of gBP21 protein. As for COI and COII, the relative transcript levels for the edited A6 and the unedited ND7 mRNAs were reduced in the null/null mutant, although to a lesser extent (for quantitative values see Fig. 5B ). Only in the case of the edited ND7 transcript did we identify a somewhat increased abundance in the null/null mutant. Non-mitochondrial transcript levels were not affected, which was verified for the α-tubulin mRNA and the transcript for HEL64, a cytosolic DEAD-box protein (50; data not shown). Guide RNA abundance in gBP21 null/null trypanosome cells Guide RNAs have been shown to stably interact with gBP21 and other mitochondrial proteins under in vitro conditions (16, 19) . Hyperchromicity measurements indicated that the RNA molecules, upon binding of the gBP21, become stabilised (18) . This suggested a protective function for the protein. To analyse whether the inability of the gBP21 null/null mutant to differentiate to the insect life cycle stage was caused by the specific degradation of gRNAs, we decided to measure the relative abundance of gRNAs in gBP21 -cells. Guide RNAs have been shown to exist in very low concentrations in steady-state RNA isolates from trypanosome cells (51), thus we performed RT-PCR amplifications. Two representative gRNAs were analysed: gA6-14, a gRNA specific for the first editing domain of the A6 mRNA; gND7-506, a gRNA specific for the editing of the 5′ editing domain of the ND7 mRNA. Previous results had demonstrated that the two molecules are expressed in both life cycle stages of the parasite (52) .
Steady-state RNA isolated from wild-type cells and the gBP21 null/null mutant resulted in identical yields. The preparations contained both gA6-14 and gND7-506 RNA, although in significantly reduced amounts compared with the abundance in insect stage trypanosomes (52; Fig. 6 ). In addition, there was notably less gND7-506 RNA than gA6-14 molecules. However, a comparison of the relative abundance of both gRNAs between wild-type and double knockout cells showed, within the variation of the method, no significant difference (Fig. 6) . Therefore, gBP21 -cells are likely to contain an unchanged gRNA pool.
Molecular assembly of gBP21
Although it has been demonstrated that gBP21 is associated with active RNA editing complexes (20) , the general reduction in mitochondrial transcripts in the gBP21 null/null mutant suggested that the protein might be involved in other mitochondrial processes as well. To experimentally address this possibility we analysed the molecular assembly of gBP21 in editing-active mitochondrial extracts. In particular, we wanted to know how In vitro RNA editing activity of gradient fractionated mitochondrial lysates. Aliquots (16 µl) of fractions 2-10 were tested for their in vitro uridylate deletion activity and analysed by denaturing PAGE (9% w/v) followed by autoradiography. The electrophoretic mobilities of the editing reactant, the U-deletion product (lacking four uridylate residues), the 3′ cleavage product as well as the main gRNA/mRNA chimeric side product are given in the margin on the right. An asterisk indicates the radioactive phosphate residue at the 3′-ends of the different RNAs. Controls were performed in the absence (-) or presence (+) of an editing-active glycerol gradient fraction (EAF). Maximal editing activity was found in fractions 5/6 or, in some gradient separations, shifted towards fractions 6/7. much of gBP21 is assembled in the high molecular mass RNA editing complex(es) (8) (9) (10) (11) and how much is assembled into other complexes or present as free protein.
Mitochondrial vesicles were isolated from late logarithmic procyclic stage trypanosomes (26) , lysed, and the extracts separated in glycerol density gradients (8) . After fractionation, aliquots from the various fractions were separated in SDS-containing polyacrylamide gels and analysed for the presence of gBP21 using a polyclonal anti-gBP21 antiserum (Fig. 7A) . gBP21 was detected in fractions 1-7. Forty-five per cent of the signal was found in fractions 1 and 2 and presumably reflect non-complexed protein.
Fractions 3-7 contained ∼50% of the signal, which covers an apparent range of ∼15-35 S. Since the protein concentration in the various fractions was dramatically different (fractions 1-3 contain the majority of the total amount of protein), we decided to additionally look at a gradient profile that analyses equal protein amounts (Fig. 7B) . The experiment demonstrated that gBP21 is specifically enriched in fractions 5-8, equivalent to an apparent S value range of ∼20-40S.
To analyse in vitro RNA editing in the various gradient fractions, we again chose the uridylate deletion assay (39) . An activity distribution with respect to the formation of the editing product from fractions 4-7 was identified (Fig. 7C) . The activity peaked in fractions 5 and 6. Fractions 4-9 contained 3′ cleavage activity and fractions 4-7 displayed chimera forming activity. Thus, only a subpopulation (35%) of the steady-state gBP21 concentration overlaps with the in vitro RNA editing activity and the majority of the protein is in a non-complexed form.
DISCUSSION
In the present work we show a combination of in vivo and in vitro results to gain insight into the biochemical function of gBP21, a polypeptide from the parasitic organism T.brucei (18) . The protein was initially identified as a component in mitochondrial extracts which, among others, could specifically be cross-linked to gRNAs (16) . Since gRNAs provide a template-like function during the RNA editing process, this suggested an involvement of gBP21 during this processing pathway.
In support of this hypothesis, we were able to demonstrate that a polyclonal antiserum directed against gBP21 is capable of inhibiting the editing reaction in vitro. Furthermore, mitochondrial protein extracts devoid of gBP21 no longer exhibit a detectable editing activity. However, as will be discussed below, these data do not indicate that the protein contributes an essential function for the editing reaction. The inhibitory effects are most likely the result of a firm association of gBP21 with the editing complex(es). As a consequence, antibody binding interferes probably on a steric level with the editing reaction or, in the case of immunodepletion, co-precipitates the entire editing machinery. This is in line with the finding of Allen et al. (20) who demonstrated that both deletional and insertional RNA editing activities can be immunoprecipitated with a monoclonal anti-gBP21 antibody. The co-precipitation of the editing machinery along with gBP21 also rationalises our failed attempt to restore RNA editing activity in immunodepleted mitochondrial extracts by the addition of recombinant gBP21.
Further support for this interpretation comes from the analysis of the gBP21 knockout trypanosome strain. gBP21 -cells are still able to synthesise edited mRNAs and have an unaltered gRNA pool. This indicates that the RNA editing machinery can be assembled without gBP21 and that this complex is functional. However, we cannot exclude that another mitochondrial component substitutes for the lack of gBP21. Molecular redundancy has been observed in many biochemical pathways (53) and could play a role here as well.
Although gBP21 is not essential, the gene disruption of both gBP21 alleles resulted in a phenotype that correlates with an impact on a mitochondrial reaction pathway. gBP21 -cells are only viable as bloodstream stage trypomastigotes which do not rely on mitochondrial activity. The cells are further characterised by an increased cell doubling time and, most importantly, have lost their ability to differentiate to the insect life cycle stage which requires mitochondrial function. On a molecular level, the abundance of exclusively mitochondrial transcripts is reduced in gBP21 -cells which is the case for edited, unedited and never-edited mRNAs alike. Three explanations can account for this phenomenon: first, mitochondrial transcription may be down-regulated, second, RNA stability may be decreased and, third, RNA turnover may be increased. Although we cannot decide which of the three processes might involve gBP21, the data clearly argue for a participation in more than one pathway. Accordingly, we were able to identify two mitochondrial gBP21 populations: free protein and gBP21 co-localising with the in vitro RNA editing activity. Thus, the protein likely acts in a non-complexed form which impacts on the stability and/or the turnover of mitochondrial transcripts, as well as in an editing complex-associated form which is non-essential for the process.
